These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23882049)

  • 1. Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes.
    Reznik Y; Cohen O
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S219-25. PubMed ID: 23882049
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A caution regarding U-500 insulin by continuous subcutaneous infusion.
    Schwartz FL
    Endocr Pract; 2004; 10(2):163-4. PubMed ID: 15278952
    [No Abstract]   [Full Text] [Related]  

  • 4. A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications.
    Tubili C; Folco UD; Nardone MR; Clementi A
    J Diabetes Sci Technol; 2017 Sep; 11(5):1057-1058. PubMed ID: 28367635
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin pumps in hospital: a guide for the generalist physician.
    Evans K
    Clin Med (Lond); 2013 Jun; 13(3):244-7. PubMed ID: 23760696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump therapy guidelines for China (July 2010).
    Mu Y; Yin S;
    J Diabetes; 2012 Jun; 4(2):127-39. PubMed ID: 22107806
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.
    Yuan G; Jia J; Zhang C; Yu S; Dong S; Ye J; Zhu T; Tang B; Qian W; Wang D; Yang L; Zhou L; Mao C
    Endocr J; 2014; 61(5):513-21. PubMed ID: 24621778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous subcutaneous insulin infusion].
    Ito H; Kanatsuka A
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on Publications from OpT2mise Study.
    Milenkovic T; Kocova M; Krstevska B; Pemovska G; Smokovski I
    Diabetes Technol Ther; 2016 Jul; 18(7):446-7. PubMed ID: 27043789
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections.
    Layne JE; Parkin CG; Zisser H
    J Diabetes Sci Technol; 2017 Jan; 11(1):178-179. PubMed ID: 27290736
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia.
    Lee IT; Liau YJ; Lee WJ; Huang CN; Sheu WH
    J Eval Clin Pract; 2010 Feb; 16(1):202-5. PubMed ID: 20367835
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion (CSII) pumps.
    Valla V
    Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
    Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application and practice of intensive insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump--a review.
    Selvan C; Ghosh S; Mukhopadhyay S
    J Indian Med Assoc; 2013 Nov; 111(11):746-50. PubMed ID: 24968483
    [No Abstract]   [Full Text] [Related]  

  • 19. Can we predict success of insulin pump therapy?
    Jankovec Z; Cesak V; Krcma M; Zourek M; Rusavy Z
    J Diabetes; 2014 Jul; 6(4):384-6. PubMed ID: 24397712
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.
    Maiorino MI; Petrizzo M; Bellastella G; Esposito K
    Endocrine; 2018 Jan; 59(1):62-65. PubMed ID: 28551774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.